Can we predict someone’s risk of developing cancer by looking at their DNA markers? In her contribution to the HEAP symposium highlights series, Chiara Herzog, Postdoctoral researcher. European …
HEAP symposium – Epigenetics and personalised preventative medicine Read More »
How does age, and lifestyle factors such as drugs, hormones, smoking, and nutrition, affect our DNA? In his contribution to the HEAP symposium highlights series, Martin Widschwendter, Director …
HEAP symposium – DNA markers, ageing and lifestyle Read More »
Can we prove that someone has been exposed to certain chemicals that have affected their health? In his contribution to the HEAP symposium highlights series, Michael Snyder, Director …
How will the Human Exposome Assessment Platform’s data analysis tools work? And how will they add value to exposome research? This HEAP symposium presentation from the platform’s lead …
HEAP symposium – Exposome data and the HEAP technical platform Read More »
How can the results of exposome research further the right to health for all? And how can this be achieved in an ethical way, respecting the rights of …
Dr. Zisis Kozlakidis is the Head of Laboratory Services and Biobanking at the International Agency for Research on Cancer (IARC/WHO). He has significant expertise in the field of …
HEAP symposium – The exposome and cancer research Read More »
What does the future hold for exposome research infrastructures in Europe? Jana Klánová is Professor of environmental chemistry at Masaryk University in Brno, Czech Republic, and coordinator of …
HEAP symposium – Infrastructures for exposome research Read More »
Is it even possible to measure the exposome? In his contribution to the HEAP Symposium highlights series, Benedikt Warth, Associate Professor at the University of Vienna and founder of …
HEAP symposium – “Measuring the exposome – delusion or next frontier?” Read More »
The next frontier of exposome research will focus on genomics, transcriptomics, proteomics, and metabolomics, and seek to identify optimal treatments for individual patients. In the next instalment of …
HEAP sympsoium – the promise of informatics and precision medicine Read More »
As part of HEAP’s “Symposium Highlights” series, Kurt Zatloukal, Head of the Diagnostic and Research Center for Molecular BioMedicine, Medical University Graz, and Director of BBMRI.at, Austria, discusses …